Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in ... An article from: Nutraceuticals World Buy on Amazon

https://www.ebooknetworking.net/books_detail-B001JTZPQU.html

Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in ... An article from: Nutraceuticals World

9.95 USD
Buy New on Amazon 🇺🇸

Available for download now

Book Details

ISBN / ASINB001JTZPQU
ISBN-13978B001JTZPQ1
AvailabilityAvailable for download now
Sales Rank99,999,999
MarketplaceUnited States  🇺🇸

Description

This digital document is an article from Nutraceuticals World, published by Rodman Publishing on March 1, 2008. The length of the article is 843 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in the digestive health category, au naturel, is explosive.(PROPRIETARY PERSPECTIVES)
Author: Anthony Almada
Publication:Nutraceuticals World (Magazine/Journal)
Date: March 1, 2008
Publisher: Rodman Publishing
Volume: 11 Issue: 3 Page: 28(2)

Distributed by Gale, a part of Cengage Learning

More Books by Anthony Almada

Donate to EbookNetworking
Prev
Next